CB Trademark

Trademark Overview


On Monday, November 18, 2019, a trademark application was filed for CB with the United States Patent and Trademark Office. The USPTO has given the CB trademark a serial number of 79275433. The federal status of this trademark filing is REGISTERED as of Tuesday, July 28, 2020. This trademark is owned by NOVARTIS AG. The CB trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
cb

General Information


Serial Number79275433
Word MarkCB
Filing DateMonday, November 18, 2019
Status700 - REGISTERED
Status DateTuesday, July 28, 2020
Registration Number6110252
Registration DateTuesday, July 28, 2020
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 12, 2020

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the intertwined letters "CB".
Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Pseudo MarkC B

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Sunday, December 6, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, November 17, 2020FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, November 17, 2020FINAL DISPOSITION PROCESSED
Wednesday, October 28, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, July 28, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, May 28, 2020CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Friday, May 15, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Tuesday, May 12, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 26, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 21, 2020REFUSAL PROCESSED BY IB
Friday, March 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, March 9, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, March 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, March 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, March 3, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, March 3, 2020REFUSAL PROCESSED BY MPU
Saturday, February 8, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, February 7, 2020NON-FINAL ACTION WRITTEN
Tuesday, February 4, 2020ASSIGNED TO EXAMINER
Tuesday, January 14, 2020APPLICATION FILING RECEIPT MAILED
Wednesday, January 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, January 2, 2020LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 2, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB